Dawaa Reference

Clinical reference

Change in hair colour

Treatment options, dosing, cautions and Egyptian brands from the shipped Dawaa Reference card.

Evidence status

Checked against the sources named below

Sources3 sources

ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class SS11.00 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care · Piebaldism - StatPearls - NCBI Bookshelf (NBK544238) - https://www.ncbi.nlm.nih.gov/books/NBK544238/

Verified against1 document
  • No dose - referral pathway, no medicine given in primary care

Verified date2026-08

1

NO DRUG THERAPY IN PRIMARY CARE (RECOGNITION & REFERRAL)

1st line
Adult dose and duration

Usually reflects normal ageing (greying) but occasionally signals a nutritional deficiency or underlying disease; primary care recognises and investigates if premature or associated with other findings. - Refer

Paediatric dose

Children follow the same pathway: recognise and refer. No primary-care medicine is implied.

Dose source

No dose - referral pathway, no medicine given in primary care

Why

Usually reflects normal ageing (greying) but occasionally signals a nutritional deficiency or underlying disease; primary care recognises and investigates if premature or associated with other findings.

Cautions
  • Premature greying with other features (fatigue, pallor) may point to an underlying nutritional deficiency or autoimmune condition.
  • No medicine is prescribed for this in primary care - this entry is for recognition and referral. Anything given is decided by the service it is referred to.

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.